Elisabeth A. Brown

Elisabeth A. Brown

Auto-generated profile, based on publicly available information

Elisabeth A. Brown

Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2026 in Science
Verified
Journal Article
Closed access
MCMeghan C. Curtin
Meghan C. Curtin
AJAbigail E. Jackson
Abigail E. Jackson
MLMark David Lee
Mark David Lee
EBElisabeth A. Brown
Elisabeth A. Brown
JMJohn Alan Maschek
John Alan Maschek
KHKeren I. Hilgendorf
Keren I. Hilgendorf
Obesity increases breast cancer risk and tumor aggressiveness, yet the mechanisms underlying this association remain unclear. In this work, we identify a tumor-suppressive lipid signaling pathway in which mammary adipocytes secrete the oxylipin 9S-hydroxyoctadecadienoic acid (9S-HODE). 9S-HODE induces ferroptosis in breast cancer cells by disrupting iron homeostasis. Adipocytes in obese mammary tissue produce less 9S-HODE, and tumors in obese mice exhibit reduced ferroptosis. Accordingly, ferroptosis inhibition accelerates tumor growth in lean mice, and restoring 9S-HODE suppresses tumor growth in obese mice. In humans, mammary 9S-HODE content is inversely correlated with body mass index, and 9S-HODE inhibits patient-derived breast cancer organoid growth. These findings identify the loss of adipocyte-derived 9S-HODE as a mechanism by which obesity promotes breast cancer and suggest that the restoration of ferroptosis-inducing lipid signaling may be a therapeutic strategy.